RBM39 and cancer: With the deepening of research, a growing number of scholars have generated a thought that RBM39, as a proto-oncogene, is not only closely related to the occurrence and development of a variety of malignant tumors, but also plays a crucial role in the clinical treatment of targeted drugs.